CERBIOS PHARMA SA

Overview

CERBIOS PHARMA SA is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering (6S)-5-METHYLTETRAHYDROFOLIC ACID CALCIUM SALT; CALCIPOTRIENE ANHYDROUS; CALCIPOTRIENE MONOHYDRATE; CALCITRIOL; CALCIUM LEVOFOLINATE; DOXERCALCIFEROL.

API / Drug Master Files

CERBIOS PHARMA SA holds 10 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TIOTROPIUM BROMIDE MONOHYDRATEActive2021-10-01
• CALCIPOTRIENE MONOHYDRATEActive2016-06-28
• LEVOFOLINIC ACID CRYSTALLINEActive2016-06-07
• TIOTROPIUM BROMIDEActive2015-01-27
• DOXERCALCIFEROLActive2014-07-03
• (6S)-5-METHYLTETRAHYDROFOLIC ACID CALCIUM SALTActive2012-04-30
• CALCIUM LEVOFOLINATEActive2010-01-04
• CALCIPOTRIENE ANHYDROUSActive2009-09-09
• CALCITRIOLActive2000-02-18
• LEUCOVORIN CALCIUMActive1983-06-30
• GLYCOPYRROLATE USPInactive2017-09-13
• VENTRUX ME30 DRUG SUBSTANCEInactive2007-07-26

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CERBIOS PHARMA SA in our records. PharmaTek screens the full directory against live FDA enforcement data.